← Leaderboards
Jennifer Yawei Ge
Harvard Medical School
$162,551
Attributed
$162,551
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2018–21$100K$75K$50K$25K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$162,551 · 1
By mechanism
F30$162,551 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Arlene H Sharpe$68,359,602
- Zachary T. Schafer$2,217,107
- Michael Chorev$1,744,295
- Loling Song$729,540
- Ioannis Zervantonakis$2,163,325
Research focus
Fatty Acid Glycerol EstersGrowthAftercareEvolutionAffectBasal CellBirthBreast Cancer Cell LineBromodeoxyuridineCd44 GeneCell GrowthCellsCell SurvivalCessation Of LifeChemotherapyClinical Trials DesignCombined Modality TherapyDiagnosisDifferentiation AntigensDisease ProgressionDna LibraryDrug SensitivityEpigenetic ProcessHeterogeneity
Grant awards (4)
Optimal BET inhibitor combination therapies in triple negative breast cancer$26,499
F30 · FY2021 · CA · contact PI
Optimal BET inhibitor combination therapies in triple negative breast cancer$50,520
F30 · FY2020 · CA · contact PI
Optimal BET inhibitor combination therapies in triple negative breast cancer$50,016
F30 · FY2019 · CA · contact PI
Optimal BET inhibitor combination therapies in triple negative breast cancer$35,516
F30 · FY2018 · CA · contact PI